Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03245658

The Effect of Cannabis in Pancreatic Cancer

The Effect of Medical Cannabis Inpatients With Palliative Pancreatic Cancer

Status
Withdrawn
Phase
Phase 2
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Jens Rikardt Andersen · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Cannabinoids are known to increase appetite, but THC components have psychogenic properties too. CBD is the main component in the plant, and have only minimal psychogenic effects. The aim was to test the appetite stimulating effects of CBD in patients with pancreatic cancer in palliative treatment.

Detailed description

Randomization of consecutive patients who wanted to participate to a daily dose of CBD or not as a supplement to the standard treatment.

Conditions

Interventions

TypeNameDescription
DRUGTHC and CBD MixtureIndividually titrated doses on daily basis

Timeline

Start date
2017-10-06
Primary completion
2018-05-06
Completion
2018-10-06
First posted
2017-08-10
Last updated
2023-12-18

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT03245658. Inclusion in this directory is not an endorsement.